Elanco Animal Health Shares Advance on Product Successes, Valuation Remains a Key Discussion Point

ソース：

[1] Elanco Animal Health’s Valuation in Focus After Breakthroughs for Credelio Quattro and Zenrelia Products (https://finance.yahoo.com/news/elanco-animal- ...)[2] Elanco Innovation Builds Momentum, Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Reaches Blockbuster Status - PR Newswire (https://vertexaisearch.cloud.google.com/groun ...)[3] Elanco's canine dermatology drug Zenrelia approved in EU By Investing.com (https://vertexaisearch.cloud.google.com/groun ...)